UPDATE 3-J&J plans more price transparency; eyes U.S. tax, healthcare changes

NEW YORK, Jan 24 (Reuters) - Johnson & Johnson'schief executive officer said on Tuesday that responsible drug
pricing is a priority and discussed changes he would like to see
on the U.S. tax code...